Tolazamide
CAS No. 1156-19-0
Tolazamide ( NSC 70762 )
Catalog No. M10547 CAS No. 1156-19-0
Tolazamide is an oral blood glucose lowering drug used for people with Type 2 diabetes.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 47 | In Stock |
|
10MG | 77 | In Stock |
|
25MG | 115 | In Stock |
|
50MG | 147 | In Stock |
|
100MG | 178 | In Stock |
|
200MG | 267 | In Stock |
|
500MG | 464 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTolazamide
-
NoteResearch use only, not for human use.
-
Brief DescriptionTolazamide is an oral blood glucose lowering drug used for people with Type 2 diabetes.
-
DescriptionTolazamide is an oral blood glucose lowering drug used for people with Type 2 diabetes.
-
SynonymsNSC 70762
-
PathwayCell Cycle/DNA Damage
-
TargetPotassium Channel
-
RecptorPotassium Channel
-
Research AreaEndocrinology
-
Indication——
Chemical Information
-
CAS Number1156-19-0
-
Formula Weight311.40
-
Molecular FormulaC14H21N3O3S
-
Purity>98%(HPLC)
-
SolubilityWater: 65.4 mg/L (at 30 °C)
-
SMILESO=C(NS(=O)(C1=CC=C(C)C=C1)=O)NN2CCCCCC2
-
Chemical Name1-(azepan-1-yl)-3-(4-methylphenyl)sulfonylurea
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Szabo C, Salzman AL. Shock. 1996 Jun;5(6):391-4.
molnova catalog
related products
-
BMS-204352
A potent and effective calcium-sensitive opener of maxi-K potassium channels (maxi-K) with EC50 of 392 nM at -48.4 mV in HEK293 isolated outside-out membrane patches.
-
PD-118057
A potent, selective hERG potassium channel (Kv11.1) activator that increases peak tail hERG current of 111.1% at 10 uM in HEK293 cells.
-
Glibornuride
Glibornuride is a blocker of ATP-sensitive K+ channel(pKi: 5.75). Glibornuride inhibits high affinity [3H]-glibenclamide binding with the potencies expected from their K+ channel activity.